Cas 85151-17-3,4-[(2-Chloro-acetylamino)-methyl]-4-hydroxy-piperidine-1-carboxylic acid benzyl ester

85151-17-3

Post Buying Request

Basic information

Product Name: 4-[(2-Chloro-acetylamino)-methyl]-4-hydroxy-piperidine-1-carboxylic acid benzyl ester
Synonyms:
CAS NO:85151-17-3
Molecular Formula:
Molecular Weight: 340.807
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-[(2-Chloro-acetylamino)-methyl]-4-hydroxy-piperidine-1-carboxylic acid benzyl ester(CAS DataBase Reference)
NIST Chemistry Reference: 4-[(2-Chloro-acetylamino)-methyl]-4-hydroxy-piperidine-1-carboxylic acid benzyl ester(85151-17-3)
EPA Substance Registry System: 4-[(2-Chloro-acetylamino)-methyl]-4-hydroxy-piperidine-1-carboxylic acid benzyl ester(85151-17-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 85151-17-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

85151-17-3 Suppliers

Recommended suppliers

85151-17-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 85151-17-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,5,1,5 and 1 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 85151-17:
(7*8)+(6*5)+(5*1)+(4*5)+(3*1)+(2*1)+(1*7)=123
123 % 10 = 3
So 85151-17-3 is a valid CAS Registry Number.

85151-17-3Upstream product

85151-17-3Downstream Products

83090-45-3 1-carbobenzoxy-4-hydroxy-4-(1-iodoacetylamidomethyl)piperidine

85151-17-3Relevant academic research and scientific papers

Antihypertensive 9-substituted 1-oxa-4,9-diazaspiro[5.5]undecan-3-ones

Clark,Caroon,Repke,Strosberg,Bitter,Okada,Michel,Whiting

, p. 855 - 861 (2007/10/02)

Forty-one 9-substituted 1-oxa-4,9-diazaspiro[5.5]undecan-3-ones were prepared for antihypertensive screening in the spontaneously hypertensive rat (SHR). For the 9-(2-indol-3-ylethyl) series, the parent compound 9-(2-indol-3-ylethyl)-1-oxa-4,9-diazaspiro[

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 85151-17-3